CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 159 filers reported holding CASTLE BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110,770 | +122.8% | 6,560 | +80.9% | 0.00% | – |
| Q2 2023 | $49,720 | -17.1% | 3,626 | +37.2% | 0.00% | – |
| Q1 2023 | $59,978 | +1.7% | 2,642 | +7.2% | 0.00% | – |
| Q4 2022 | $59,000 | -9.2% | 2,464 | -2.4% | 0.00% | – |
| Q3 2022 | $65,000 | +25.0% | 2,524 | +6.6% | 0.00% | – |
| Q2 2022 | $52,000 | -81.4% | 2,368 | -62.1% | 0.00% | -100.0% |
| Q1 2022 | $279,000 | -10.0% | 6,247 | -13.8% | 0.00% | 0.0% |
| Q4 2021 | $310,000 | -29.1% | 7,245 | +10.3% | 0.00% | 0.0% |
| Q3 2021 | $437,000 | -1.6% | 6,567 | +8.2% | 0.00% | 0.0% |
| Q2 2021 | $444,000 | +111.4% | 6,072 | +98.0% | 0.00% | 0.0% |
| Q1 2021 | $210,000 | +36.4% | 3,066 | +33.8% | 0.00% | – |
| Q4 2020 | $154,000 | +7600.0% | 2,292 | +5109.1% | 0.00% | – |
| Q3 2020 | $2,000 | – | 44 | +2100.0% | 0.00% | – |
| Q2 2020 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |